Thrombosis and Anticoagulation Program

Led by Alan Michelson, MD, one of the world’s leading authorities on platelets and platelet disorders, the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center’s Thrombosis and Anticoagulation Program treats children with all forms of blood clots and clotting disorders. The disorders we treat in the program include pulmonary embolism, sinus venous thrombosis, deep vein thrombosis, and arterial thrombosis. Our emphasis is on preventing blood clots, especially thrombosis, before they occur and treating them if they do.

Dana-Farber/Boston Children’s is an integrated pediatric hematology and oncology partnership between Dana-Farber Cancer Institute and Boston Children’s Hospital. We offer, in one specialized program, the full spectrum of services that are needed for diagnosis, treatment and ongoing care of even the rarest and hard-to-treat conditions.

Patients seen through the Thrombosis and Anticoagulation Program are treated by a multidisciplinary team of specialists with deep expertise in the conditions we treat. Our team also includes pediatric subspecialists with extensive experience treating blood clots and a designated nurse who specializes in medications that thin the blood and prevent clots from forming.

Learn more about our Thrombosis and Anticoagulation Program on the Dana-Farber/Boston Children’s website.